Last update:

Inflammatory disorders news

Cardiology

Research shows GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis patients treated with glucagon-like peptide-1 receptor agonists (GLP-1RAs) face a 78% lower risk of death and a 44% lower risk of major cardiovascular events compared to those taking other diabetes or weight-loss ...

Ophthalmology

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

New research presented at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that people with psoriasis face a significantly increased risk of developing age-related macular degeneration (AMD), ...

Inflammatory disorders

'Creeping fat' can worsen Crohn's disease, study finds

Fat is more complicated than we thought. Once considered just a bag of calories, scientists now know that our fat—aka adipose tissue—doesn't just squirrel away energy; it also sends and receives hormonal, nervous system ...

Dentistry

Mediterranean diet may reduce gum disease

People living in the U.K. and following a diet close to the Mediterranean diet are more likely to have better gum health, with potentially lower amounts of gum disease and inflammation.

Inflammatory disorders

GLP1 weight loss injections may reduce asthma symptoms

GLP1 agonist drugs, commonly known by brand names such as Ozempic and Mounjaro, reduce asthma symptoms in obese people according to a new study from the University of Aberdeen and the Observational and Pragmatic Research ...

Psychology & Psychiatry

Alopecia areata associated with severe psychosocial impact

Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity, according to a study published online July 16 in the British Journal of Dermatology.

Inflammatory disorders

The future of skin allergy testing

Skin allergies are common and often frustrating to diagnose. But new technology could soon help change that.

Inflammatory disorders

New 3D tissue model may speed better therapies for fibrosis

For the 300,000 Americans living with the immune disease scleroderma, better treatments can't come soon enough. The rare and sometimes fatal illness stiffens and scars tissue in organs like the lungs, liver, and kidneys, ...

Inflammatory disorders

Management of chronic rhinosinusitis may be improving

During the past five years, there has been a marked reduction in chronic rhinosinusitis (CRS) severity, according to a study published online June 17 in Biomedical Reports.